Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Mural Oncology's share price for the quarter that ended in Mar. 2024 was $4.89. Mural Oncology's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 16.92 Mil. Therefore, Mural Oncology's market cap for the quarter that ended in Mar. 2024 was $82.75 Mil.
Mural Oncology's quarterly market cap
increased
from Sep. 2023 ($0.00 Mil) to Dec. 2023 ($98.80 Mil) but then
declined
from Dec. 2023 ($98.80 Mil) to Mar. 2024 ($82.75 Mil).
Mural Oncology's annual market cap
stayed the same
from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($0.00 Mil) but then
increased
from Dec. 2022 ($0.00 Mil) to Dec. 2023 ($98.80 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Mural Oncology's Enterprise Value for Today is $-163.19 Mil.
Mural Oncology Market Cap Historical Data
The historical data trend for Mural Oncology's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Mural Oncology's Market Cap
For the Biotechnology subindustry, Mural Oncology's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mural Oncology's Market Cap Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Mural Oncology's Market Cap distribution charts can be found below:
* The bar in red indicates where Mural Oncology's Market Cap falls into.
Mural Oncology Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Mural Oncology's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mural Oncology (NAS:MURA) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Mural Oncology Market Cap Related Terms
Thank you for viewing the detailed overview of Mural Oncology's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Mural Oncology (Mural Oncology) Business Description
Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging their core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. The Company operates as one business segment, which is the business of developing medicines designed to address unmet medical needs of patients in the area of oncology.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MURA has been successfully added to your 